Latest Breaking News On - ஊடாய் சகஷெண - Page 2 : comparemela.com

Anti-Diabetic Drug Can Be Repurposed For Safe, Cost-Effective Treatment Of COVID-19, Finds Study

Anti-Diabetic Drug Can Be Repurposed For Safe, Cost-Effective Treatment Of COVID-19, Finds Study
swarajyamag.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from swarajyamag.com Daily Mail and Mail on Sunday newspapers.

Andhra pradeshUday saxenaSubramanyam vangalaSreedhara voletiReagene innovations privateUniversity of hyderabad uoUniversity of hyderabadReagene innovations private limitedReagene innovationsPatent cooperation treatyஆந்திரா பிரதேஷ்ஊடாய் சகஷெணசுப்ரமணியம் வங்காளபல்கலைக்கழகம் ஆஃப் ஹைதராபாத் ஊஓபல்கலைக்கழகம் ஆஃப் ஹைதராபாத்காப்புரிமை ஒத்துழைப்பு ஒப்பந்தம்

UoH-incubated startup awarded for 3D models to study diseases

UoH-incubated startup awarded for 3D models to study diseases
thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.

Subrahmanyam vangalaUday saxenaReagene biosciencesIssar pharmaUniversity of hyderabad uoTech mahindraScientific pursuitsInnovative research enterprisesஸப்ராம்யாநியம் வங்காளஊடாய் சகஷெணவழங்குபவர் பார்மாபல்கலைக்கழகம் ஆஃப் ஹைதராபாத் ஊஓதொழில்நுட்பம் மஹிந்திராஅறிவியல் நாட்டங்கள்புதுமையானது ஆராய்ச்சி நிறுவனங்கள்

ChemTECH BioPharma World IE Conference to cover nuances of biopharmaceuticals

ChemTECH BioPharma World.IE Conference to cover nuances of biopharmaceuticals ChemTECH BioPharma World.IE Conference to cover nuances of biopharmaceuticals 19 January 2021 | News The conference will also focus on the Bio Start-ups through the Accelerating Bio-Innovations to Marketplace session The ChemTECH BioPharma World.IE Conference is set to explore and address the opportunity & the challenge through ChemTECH Biopharma World.IE Conference - Bio-Pharmaceuticals: A Next Big Opportunity, to be held from Feb 24 to Feb 26, 2021. The opportunity in biopharmaceuticals is big and growing too rapidly to ignore. Today, biopharmaceuticals generate global revenues of $163 billion, making up about 20 percent of the pharma market.

Uday saxenaDinesh duaReagene biosciencesVishal gandhiNectar lifesciencesBiorx venture advisors privateNext big opportunityExecutive directorNectar lifesciences limitedDigital transformationSupply chainBio start upsAccelerating bio innovationsVenture advisors privateKnowedge partnerBio pharma